Education and Knowledge in Pharmacogenomics: Still a Challenge?

Jyothsna Giri, Timothy B Curry, Christine M. Formea, Wayne T. Nicholson, Carolyn R. Rohrer Vitek

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A number of barriers exist for adoption of pharmacogenomics into practice. Physicians, pharmacists, and nurses report limited knowledge about pharmacogenomics and its use in patient care. Lack of pharmacogenomics education curricula as part of professional schools or postgraduate training programs has been reported as a potential cause. Understanding pharmacogenomics is further complicated by a complex and nonstandard lexicon, limited medication guidelines, rapidly changing evidence, and insufficient awareness of test availability and utility.

Original languageEnglish (US)
JournalClinical Pharmacology and Therapeutics
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Pharmacogenetics
Education
Pharmacists
Curriculum
Patient Care
Nurses
Guidelines
Physicians

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Education and Knowledge in Pharmacogenomics : Still a Challenge? / Giri, Jyothsna; Curry, Timothy B; Formea, Christine M.; Nicholson, Wayne T.; Rohrer Vitek, Carolyn R.

In: Clinical Pharmacology and Therapeutics, 01.01.2018.

Research output: Contribution to journalArticle

Giri, Jyothsna ; Curry, Timothy B ; Formea, Christine M. ; Nicholson, Wayne T. ; Rohrer Vitek, Carolyn R. / Education and Knowledge in Pharmacogenomics : Still a Challenge?. In: Clinical Pharmacology and Therapeutics. 2018.
@article{07366ab045ee48ef8239189e461f0b92,
title = "Education and Knowledge in Pharmacogenomics: Still a Challenge?",
abstract = "A number of barriers exist for adoption of pharmacogenomics into practice. Physicians, pharmacists, and nurses report limited knowledge about pharmacogenomics and its use in patient care. Lack of pharmacogenomics education curricula as part of professional schools or postgraduate training programs has been reported as a potential cause. Understanding pharmacogenomics is further complicated by a complex and nonstandard lexicon, limited medication guidelines, rapidly changing evidence, and insufficient awareness of test availability and utility.",
author = "Jyothsna Giri and Curry, {Timothy B} and Formea, {Christine M.} and Nicholson, {Wayne T.} and {Rohrer Vitek}, {Carolyn R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/cpt.1019",
language = "English (US)",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Education and Knowledge in Pharmacogenomics

T2 - Still a Challenge?

AU - Giri, Jyothsna

AU - Curry, Timothy B

AU - Formea, Christine M.

AU - Nicholson, Wayne T.

AU - Rohrer Vitek, Carolyn R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - A number of barriers exist for adoption of pharmacogenomics into practice. Physicians, pharmacists, and nurses report limited knowledge about pharmacogenomics and its use in patient care. Lack of pharmacogenomics education curricula as part of professional schools or postgraduate training programs has been reported as a potential cause. Understanding pharmacogenomics is further complicated by a complex and nonstandard lexicon, limited medication guidelines, rapidly changing evidence, and insufficient awareness of test availability and utility.

AB - A number of barriers exist for adoption of pharmacogenomics into practice. Physicians, pharmacists, and nurses report limited knowledge about pharmacogenomics and its use in patient care. Lack of pharmacogenomics education curricula as part of professional schools or postgraduate training programs has been reported as a potential cause. Understanding pharmacogenomics is further complicated by a complex and nonstandard lexicon, limited medication guidelines, rapidly changing evidence, and insufficient awareness of test availability and utility.

UR - http://www.scopus.com/inward/record.url?scp=85041673241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041673241&partnerID=8YFLogxK

U2 - 10.1002/cpt.1019

DO - 10.1002/cpt.1019

M3 - Article

C2 - 29417560

AN - SCOPUS:85041673241

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

ER -